Everything below concerns gastric juice protein. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-04-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic pentadecapeptide | Fifteen amino acids; sequence matches a fragment of a gastric juice protein |
| Molecular formula | C62H98N16O22 | Corresponds to a molecular mass near 1419 Da |
| Primary origin | Fragment of human gastric juice protein BPC | First characterized in the early 1990s |
| Common synonyms | BPC 157; PL 14736; pentadecapeptide BPC 157 | Naming conventions vary across publications |
| Reported stability | Stable in gastric juice during in vitro incubation | Based on laboratory incubation, not clinical data |
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
=== Cuisine === Ghanaian cuisine includes an assortment of soups and stews with varied seafoods; most Ghanaian soups are prepared with vegetables, meat, poultry or fish. Fish is in the diet with tilapia, roasted and fried whitebait, smoked fish and crayfish, all being components of Ghanaian dishes. Banku (akple) is a starchy food made from ground corn (maize), and cornmeal based staples kɔmi (kenkey) and banku (akple) may be accompanied by some form of fried fish (chinam) or grilled tilapia and a spicy condiment made from raw red and green chillies, onions and tomatoes (pepper sauce). Banku and tilapia is a combo served in some restaurants. Fufu is the most common exported Ghanaian dish and is a delicacy across the African diaspora. Rice is an established staple meal across the country, with various rice-based dishes serving as breakfast, lunch and dinner, the main variants are waakye, plain rice and stew (either kontomire or tomato gravy), fried rice and jollof rice.
=== Muscle repair === Stem cells have successfully been used to ameliorate healing in the heart after myocardial infarction in dogs. Adipose and bone marrow derived stem cells were removed and induced to a cardiac cell fate before being injected into the heart. The heart was found to have improved contractility and a reduction in the damaged area four weeks after the stem cells were applied. In 2007, a trial was underway for a patch made of a porous substance onto which the stem cells are "seeded" in order to induce tissue regeneration in heart defects. Tissue was regenerated and the patch was well incorporated into the heart tissue. This is thought to be due, in part, to improved angiogenesis and reduction of inflammation. Although cardiomyocytes were produced from the mesenchymal stem cells, they did not appear to be contractile. Other treatments that induced a cardiac fate in the cells before transplanting had greater success at creating contractile heart tissue. 2018 research, such as the European nTRACK research project, aims to demonstrate that multimodal nanoparticles can structurally and functionally track stem cell in muscle regeneration therapy. The idea is to label stem cells with gold nano-particles that are fully characterised for uptake, functionality, and safety. The labelled stem cells will be injected into an injured muscle and tracked using imaging systems. However, the system still needs to be demonstrated at lab scale.
=== India === In India, Entamoeba is the most common cause of food illness, followed by Campylobacter bacteria, Salmonella bacteria, E. coli bacteria, and norovirus. According to statistics, food poisoning was the second most common cause of infectious disease outbreak in India in 2017. The numbers of outbreaks have increased from 50 in 2008 to 242 in 2017.
== Proteins == The two main components of the soybean important in tofu making are the 11S component, containing glycinin, and the 7S subunit, containing hemagglutinins, lipoxygenases, b-amylase, and β-conglycinin. The major soy protein components, in the two fractions that make up 65–85% of the proteins in soybeans, include glycinin and β-conglycinin. The soybean protein consists of many different subunits, which are sensitive to heat, pH, and ionic strength and become unevenly distributed among soluble and particulate fractions due to hydrophilic and hydrophobic interaction because of the amino acid composition.
Sources: en.wikipedia.org
shuttle vector A DNA molecule (e.g. a plasmid), natural or engineered, that is capable of replicating in two or more different host organisms and which can therefore be used to convey genetic material between them.
He considered the West Midlands dialect of Middle English to be his own "native language", and, as he wrote to W. H. Auden in 1955, "I am a West-midlander by blood (and took to early west-midland Middle English as a known tongue as soon as I set eyes on it)."
==== Emergence ==== Prior to the formation of the Zaporozhian Sich, Cossacks had usually been organized by Ruthenian boyars, or princes of the nobility, especially various Lithuanian starostas. Merchants, peasants, and runaways from the Polish–Lithuanian Commonwealth, Muscovy, and Moldavia also joined the Cossacks. It has been argued that the first sich prototype was formed by the starosta of Cherkasy and Kaniv, Dmytro Vyshnevetsky, who built Khortytsia Castle on the island of "Little Khortytsia" on the banks of the Lower Dnieper in the 1550s. The Zaporozhian Host adopted a lifestyle that combined the ancient Cossack order and habits with those of the Knights Hospitaller. The Cossack structure arose, in part, in response to the struggle against Tatar raids. Socio-economic developments in the Polish-Lithuanian Commonwealth were another important factor in the growth of the Ukrainian Cossacks. During the 16th century, serfdom was imposed because of the favorable conditions for grain sales in Western Europe. This subsequently decreased the locals' land allotments and freedom of movement. In addition, the Polish-Lithuanian Commonwealth government attempted to impose Catholicism, and to Polonize the local Ukrainian population. The basic form of resistance and opposition by the locals and burghers was flight and settlement in the sparsely populated steppe.
Sources: en.wikipedia.org
=== Australia === Nando's has been in continuous operation within Australia since 1990, when the first restaurant opened in Tuart Hill in Western Australia. As of August 2021, there were 155 restaurants in Australia; 63 in Victoria, 36 in Western Australia, 30 in Queensland, 16 in New South Wales, four in South Australia, two in the Northern Territory, three in Tasmania and two in the Australian Capital Territory. Per city, there are 59 in Melbourne, 34 in Perth, 20 in Brisbane, 15 in Sydney, four each in Adelaide and the Gold Coast, three in Ipswich, two each in Hobart, Canberra and Darwin and one each in Ballarat, Bunbury, Geelong, Kalgoorlie, Launceston, Newcastle, Rockhampton, Shepparton, the Sunshine Coast, Townsville and Traralgon. There have been various public battles between the parent company and its Australian franchisees.
He is a co-founder and board member of the Institute for the Study of Panspermia and Astroeconomics, set up in Japan in 2014, and the Editor-in-Chief of the Journal of Astrobiology & Outreach. He was a Visiting By-Fellow, Churchill College, Cambridge, England 2015/16; Professor and Director of the Buckingham Centre for Astrobiology at the University of Buckingham, a post he has held since 2011; Affiliated Visiting Professor, University of Peradeniya, Sri Lanka; and a board member and research director at the Institute for the Study of Panspermia and Astroeconomics, Ogaki-City, Gifu, Japan. In 2017, Wickramasinghe was appointed adjunct professor in the Department of Physics, at the University of Ruhuna, Matara, Sri Lanka.
The panel attributed many of the deaths to natural causes or substandard care, citing issues such as inadequate staffing and delays in essential treatment, and argued that the deaths were unrelated to deliberate actions by Letby. On 14 September 2026, Helen Shannon, a chemical engineering expert, and Geoff Chase, a professor of bioengineering, resigned from Letby's legal team, saying that some of the arguments being put forward on Letby's behalf regarding two infants were "inconsistent with the available evidence, science and established physiology".
Sources: en.wikipedia.org
It is a synthetic peptide of fifteen amino acids whose sequence matches a fragment of a protein found in human gastric juice. It is studied mainly in laboratory and animal research rather than as an approved medicine.
The letters abbreviate body protection compound, the name given to the parent protein isolated from gastric juice. The number is an identifier attached to the specific fragment, not a dose or a description of a chemical property.
The sequence corresponds to a segment of an endogenous gastric protein, but the isolated fifteen-amino-acid peptide is a synthetic construct. Whether the free fragment circulates in humans at measurable levels is not clearly established in the published literature.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence corresponds to a fragment of a protein found in human gastric juice. It is studied mainly in preclinical research and is not an approved pharmaceutical product in major markets. Materials sold for laboratory use are typically labelled as research chemicals.